Clinical trial

Chromium Picolinate for the Treatment of Metabolic Syndrome

NCT00128154

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-01-01

PhaseNA

Study timeline

Study start (unknown)2004-01-01Date precision: month

Registry last updated2006-08-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metabolic Syndrome Xunresolved

Prediabetic Stateunresolved

Insulin Resistanceunresolved

Obesityunresolved

Metabolic Diseasesunresolved

Interventions

Chromium picolinateDRUG · verified · RxNorm: chromium picolinate

Sponsors & collaborators

National Center for Complementary and Integrative Health (NCCIH)lead sponsor

Mapped research locations

PhiladelphiaPennsylvania, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00128154 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.